前列腺素E1联合腺苷钴胺治疗带状疱疹神经痛疗效观察

Clinical observation on Lipo PGE1 in combination with cobamamide for neuralgia in patients with herpes zoster

  • 摘要: 目的:观察前列腺素E1脂微球载体制剂(Lipo PGE1)联合腺苷钴胺治疗带状疱疹神经痛的疗效和安全性。方法:66例带状疱疹神经痛患者随机均分为2组,对照组给予阿昔洛韦、阿米替林及半导体激光治疗,治疗组在对照组治疗的基础上,加用Lipo PGE1及腺苷钴胺治疗,疗程1周。结果:治疗组与对照组的有效率分别为84.8%、63.6%,两组比较有显著性差异(P<0.05);治疗后3月内随访,治疗组疼痛积分、带状疱疹后遗神经痛发生率显著低于对照组。结论:前列腺素E1脂微球载体制剂(Lipo PGE1)联合腺苷钴胺治疗带状疱疹神经痛安全、有效,并对后遗神经痛有较好的预防作用。

     

    Abstract: Objective:To observe the efficacy and safety of combined therapy of Lipo PGE1 and cobamamide in the treatment of neuralgia in Herpes zoster.Methods: 66 patients with neuralgia of Herpes zoster were randomly divided into 2 groups: control group were treated with acyclovir,amitriptyline and semi-conductor laser,treatment group were administrated with Lipo PGE1 and cobamamide additionally based on the management of control group.The two groups were both treated for 1 week.Results: The effective rates(ER) for treatment group and control group were 84.8% and 63.6% respectively.Great significances were found between two groups(P<0.05).Pain score and the incidence of postherpetic neuralgia of treatment group were lower than that of control group in 3 months after the treatment.Conclusion: Combined therapy of Lipo PGE1 and cobamamide is safe and effective for the treatment of neuralgia in Herpes zoster and can prevent postherpetic neuralgia in some degree.

     

/

返回文章
返回